Karsan N, Goadsby P
CNS Drugs. 2024; 38(7):533-546.
PMID: 38822165
DOI: 10.1007/s40263-024-01091-2.
Mitsikostas D, Waeber C, Sanchez-Del-Rio M, Raffaelli B, Ashina H, Brink A
Nat Rev Neurol. 2023; 19(8):489-505.
PMID: 37438431
DOI: 10.1038/s41582-023-00842-x.
Kortesi T, Spekker E, Vecsei L
Cells. 2022; 11(23).
PMID: 36497053
PMC: 9736455.
DOI: 10.3390/cells11233795.
Viticchi G, Falsetti L, Silvestrini M, Bartolini M
Neurol Sci. 2022; 43(9):5709-5716.
PMID: 35816257
DOI: 10.1007/s10072-022-06260-z.
Tuka B, Nyari A, Cseh E, Kortesi T, Vereb D, Tomosi F
J Headache Pain. 2021; 22(1):60.
PMID: 34171996
PMC: 8229298.
DOI: 10.1186/s10194-021-01239-1.
Vascular actions of peripheral CGRP in migraine-like photophobia in mice.
Mason B, Wattiez A, Balcziak L, Kuburas A, Kutschke W, Russo A
Cephalalgia. 2020; 40(14):1585-1604.
PMID: 32811179
PMC: 7785273.
DOI: 10.1177/0333102420949173.
Migraine, dyspepsia, and Helicobacter pylori: Zeroing in on the culprit.
Akbari N, Hormati A, Sharifipour E, Hejazi S, Jafari F, Mousavi-Aghdas S
Iran J Neurol. 2019; 18(1):19-24.
PMID: 31316732
PMC: 6626606.
Traditional and Novel Migraine Therapy in the Aging Population.
Mathew S, Ailani J
Curr Pain Headache Rep. 2019; 23(6):42.
PMID: 31079259
DOI: 10.1007/s11916-019-0789-6.
Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches.
Frederiksen S, Haanes K, Warfvinge K, Edvinsson L
J Cereb Blood Flow Metab. 2017; 39(4):610-632.
PMID: 29251523
PMC: 6446417.
DOI: 10.1177/0271678X17747188.
Triptans and CGRP blockade - impact on the cranial vasculature.
Benemei S, Cortese F, Labastida-Ramirez A, Marchese F, Pellesi L, Romoli M
J Headache Pain. 2017; 18(1):103.
PMID: 29019093
PMC: 5635141.
DOI: 10.1186/s10194-017-0811-5.
Pathophysiology of Migraine: A Disorder of Sensory Processing.
Goadsby P, Holland P, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S
Physiol Rev. 2017; 97(2):553-622.
PMID: 28179394
PMC: 5539409.
DOI: 10.1152/physrev.00034.2015.
Neurovascular contributions to migraine: Moving beyond vasodilation.
Jacobs B, Dussor G
Neuroscience. 2016; 338:130-144.
PMID: 27312704
PMC: 5083225.
DOI: 10.1016/j.neuroscience.2016.06.012.
Drug interactions with triptans : which are clinically significant?.
Rolan P
CNS Drugs. 2012; 26(11):949-57.
PMID: 23018546
DOI: 10.1007/s40263-012-0002-5.
MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.
Ishii M, Shimizu S, Sakairi Y, Nagamine A, Naito Y, Hosaka Y
Mol Cell Biochem. 2011; 363(1-2):357-66.
PMID: 22193458
DOI: 10.1007/s11010-011-1188-4.
Chemical mediators of migraine: preclinical and clinical observations.
Gupta S, Nahas S, Peterlin B
Headache. 2011; 51(6):1029-45.
PMID: 21631491
PMC: 3986727.
DOI: 10.1111/j.1526-4610.2011.01929.x.
The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.
Park H, Lee S, Shim J, Kim B, Hwang S, Kim S
J Clin Neurol. 2010; 2(4):246-51.
PMID: 20396527
PMC: 2854974.
DOI: 10.3988/jcn.2006.2.4.246.
Migraine pain: reflections against vasodilatation.
Panconesi A, Bartolozzi M, Guidi L
J Headache Pain. 2009; 10(5):317-25.
PMID: 19499287
PMC: 3452097.
DOI: 10.1007/s10194-009-0130-6.
Current and prospective pharmacological targets in relation to antimigraine action.
Mehrotra S, Gupta S, Chan K, Villalon C, Centurion D, Saxena P
Naunyn Schmiedebergs Arch Pharmacol. 2008; 378(4):371-94.
PMID: 18626630
DOI: 10.1007/s00210-008-0322-7.
The role of serotonin in the pathogenesis and clinical presentations of migraine attacks.
Izzati-zade K
Neurosci Behav Physiol. 2008; 38(5):501-5.
PMID: 18607750
DOI: 10.1007/s11055-008-9008-3.
Dialysis headache.
Antoniazzi A, Corrado A
Curr Pain Headache Rep. 2007; 11(4):297-303.
PMID: 17686394
DOI: 10.1007/s11916-007-0207-3.
